Simply Wall St.
We're Keeping An Eye On Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Rate
➖
AI Sentiment
Neutral
4/10
Zentalis Pharmaceuticals Inc. News
Latest updates and market news for ZNTL
1 news
Nov 29 - Dec 5, 2025
Page 1
Share this news page